In Vitro Activities of Linezolid against Important Gram-Positive Bacterial Pathogens Including Vancomycin-Resistant Enterococci (original) (raw)

In vitro efficacy of linezolid against vancomycin resistant Enterococci

Pakistan journal of pharmaceutical sciences, 2018

Comparative activity of linezolid against staphylococci and enterococci isolated in Italy

Clinical Microbiology and Infection, 2002

Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus, Coagulase-Negative Staphylococci, Enterococcus faecalis, and Enterococcus faecium

Glenn Kaatz

1998

View PDFchevron_right

Comparative Antimicrobial Activities of Linezolid and Vancomycin against Gram-Positive Clinical Isolates from Hospitals in Kuwait

Edet Udo

Medical Principles and Practice, 2001

View PDFchevron_right

Linezolid: a promising option in the treatment of Gram-positives

Mohammad Asgharzadeh

Journal of Antimicrobial Chemotherapy, 2016

View PDFchevron_right

In vitro activity of linezolid alone and combined with other antibiotics against clinical enterococcal isolates

A. Rajabi

Wiener Medizinische Wochenschrift, 2017

View PDFchevron_right

Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections

Namirah Jamshed

American family physician, 2002

View PDFchevron_right

Linezolid use in Medicin Therapy against Multiresistant Bacteria-A Review

Ferdinando Agostinho

Journal of Bacteriology & Parasitology, 2017

View PDFchevron_right

Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Joyce Broyles, Marion Kainer, Rose Devasia

Emerging Infectious Diseases, 2007

View PDFchevron_right

Linezolid for the treatment of infections caused by Gram-positive pathogens in China

Rodney Dabrera

International Journal of Antimicrobial Agents, 2008

View PDFchevron_right

Association of Pharmacokinetic and Pharmacodynamic Aspects of Linezolid with Infection Outcome

Ioannis Kioumis

Current Drug Metabolism, 2009

View PDFchevron_right

In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: an area with a high prevalence of antibiotic resistance

Abdul Hannan

International Journal of Antimicrobial Agents, 2001

View PDFchevron_right

Optimization of Linezolid Dosing Regimens for Treatment of Vancomycin-Resistant Enterococci Infection

สุดาลักษณ์ ธัญญาหาร

Infection & Chemotherapy

View PDFchevron_right

Linezolid and its derivatives: the promising therapeutic challenge to multidrug-resistant pathogens

Luana Calabrone

2018

View PDFchevron_right

Clinical experience with linezolid in the treatment of resistant gram-positive infections

Suresh Antony

Journal of the National …, 2001

View PDFchevron_right

Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains

GÜLSEREN AKTAŞ

Archives of Medical Science, 2020

View PDFchevron_right

Anti-Microbial Susceptibility Pattern of Linezolid in Various Clinical Isolates

Naeem Akhtar

UK Journal of Pharmaceutical Biosciences, 2016

View PDFchevron_right

In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods

Jocelyne Caillon, Cédric Jacqueline, Gilles Potel

2003

View PDFchevron_right

Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms

Alicia Herrero

International Journal of Antimicrobial Agents, 2013

View PDFchevron_right

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci

Kayla Stover

Pharmacy, 2021

View PDFchevron_right

In Vitro Bactericidal Activities of Linezolid in Combination with Vancomycin, Gentamicin, Ciprofloxacin, Fusidic Acid, and Rifampin against Staphylococcus aureus

M. Kitzis, P. Grohs

Antimicrobial Agents and Chemotherapy, 2003

View PDFchevron_right

Comparison of Linezolid and Daptomycin in the Treatment of Vancomycin-Resistant Enterococcal Bacteremia

Jason Gallagher

Infectious Diseases in Clinical Practice, 2011

View PDFchevron_right

Linezolid vancomycin resistant Enterococcus isolated from clinical samples in Tehran hospitals

S. Yasliani, Omid Teymournejad

Indian Journal of Medical Sciences, 2009

View PDFchevron_right

In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus

Jose Arce

View PDFchevron_right

In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides

Francesc Gudiol

European Journal of Clinical Microbiology & Infectious Diseases, 2010

View PDFchevron_right

In Vitro Activities of Linezolid against Important Gram-Positive Bacterial Pathogens Including Vancomycin-Resistant Enterococci (original) (raw)

Related papers